<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01643629</url>
  </required_header>
  <id_info>
    <org_study_id>KRPL/HPL-AGA/11-12/001A</org_study_id>
    <nct_id>NCT01643629</nct_id>
  </id_info>
  <brief_title>A Study to Determine the Safety and Efficacy of Autologous Human Platelet Lysate for Treatment of Androgenetic Alopecia</brief_title>
  <official_title>A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For Treatment Of Androgenetic Alopecia (AGA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasiak Research Pvt. Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasiak Research Pvt. Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicentre, open label, randomized, pilot study to evaluate safety and efficacy of
      Human Platelet Lysate (HPL) in subjects with Androgenetic Alopecia. The study is being
      conducted at 2 centers in India. The primary endpoints are Improvement in Caliber &amp; Density
      of hair and Improvement in Photographic assessment from randomization to end of study. The
      secondary endpoints are Physicians and Patients self assessment score.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">November 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Calibre &amp; Density of Hair as assessed by Folliscope</measure>
    <time_frame>Day 0, Month 4, End of study - Month 6</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Photographic Assessment</measure>
    <time_frame>Day 0, Month1, Month 2, Month 3, Month 4, Month 5, Month 6</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Physician's Assessment Score</measure>
    <time_frame>End of study - Month 6</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient's Assessment Score</measure>
    <time_frame>End of study - Month 6</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Androgenetic Alopecia</condition>
  <arm_group>
    <arm_group_label>Study arm A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Study arm A will include subjects receiving three doses of Autologous Human Platelet Lysate at an interval of one month each.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control arm B will include subjects receiving Standard therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous Human Platelet Lysate (HPL)</intervention_name>
    <description>Study arm A will include subjects receiving three doses of Autologous Human Platelet Lysate at an interval of one month each.</description>
    <arm_group_label>Study arm A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>2 % Minoxidil and /or Finasteride</intervention_name>
    <description>Control arm B subjects will receive Standard therapy (2% Minoxidil and/or Finasteride)</description>
    <arm_group_label>Control Arm B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male subjects, aged between 18 to 50 years (both inclusive) and in general good health

          -  Subjects willing to refrain from other AGA treatments during the entire study duration

          -  Subjects who are willing to give informed consent and adhere to the study protocol.

        Exclusion Criteria:

          -  Subjects aged &lt;18 or &gt; 50 years

          -  Subjects with dermatological disorder of scalp that might interfere with study
             evaluation

          -  Subjects on Anti-coagulant therapy

          -  Subjects with clinically significant medical or psychiatric disease as determined by
             the investigator.

          -  Subjects with dermatological disorder of scalp that might interfere with study
             evaluation

          -  Subjects unwilling to or unable to comply with the study protocol.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rajendarsingh Rajput, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dr. Rajesh Rajput Hair Restore</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sandeep Sattur, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hairrevive</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kasiak Research Pvt Ltd</name>
      <address>
        <city>Thane</city>
        <state>Maharashtra</state>
        <zip>400610</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2012</study_first_submitted>
  <study_first_submitted_qc>July 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2012</study_first_posted>
  <last_update_submitted>July 24, 2012</last_update_submitted>
  <last_update_submitted_qc>July 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alopecia</mesh_term>
    <mesh_term>Alopecia Areata</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Finasteride</mesh_term>
    <mesh_term>Minoxidil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

